Explore the latest press releases and important announcements from InGeneron.
InGeneron, Inc. Announces EU Quality Management System Certificate Under MDR Regulation (EU) 2017/745 for Medical Devices
InGeneron Publishes Landmark Study Demonstrating Structural Tendon Regeneration with Autologous Cell Therapy System
InGeneron Reports Positive Long-Term Results for its Cell Therapy in Partial-Thickness Rotator Cuff Tears
InGeneron Announces Encouraging Results from Emory University’s 480-Patient Phase III Knee Osteoarthritis Trial
New Study Reports Broad Applicability of InGeneron’s Regenerative Cell Therapy System Across Patient Groups
InGeneron Publishes Overview on Current State and Potential of Regenerative Cell Therapy in Orthopedics
American Medical Association Issues New CPT® Category III Codes for InGeneron’s Cell Therapy for Rotator Cuff Tears
InGeneron Publishes Significant Support for the Existence of Naturally Pluripotent Stem Cells in All Organs in the Adult Body
InGeneron Reports First-In-Human Microscopic Evidence of Adult Tendon Regeneration Following Autologous Stem Cell Treatment
InGeneron Announces Publication of Rotator Cuff Feasibility Study
InGeneron Announces Publication of Preclinical Results for its Cell Therapy in Chronic Ischemic Heart Failure
InGeneron Extends Series D Financing to $43 Million to Bring Regenerative Cell Therapy into the Clinic
In the US InGeneron’s Transpose® RT cell therapy platform is for investigational use only. By Clicking ‘Continue’ I confirm acknowledgment
